Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio

Purpose. As one of the most common chronic liver diseases, metabolic dysfunction-associated fatty liver disease (MAFLD) had different prognoses between mild and moderate-severe levels. Serum uric acid to serum creatinine ratio (sUA/Cr) can reflect the overall metabolic status of the body. To explore...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Liu, Hongye Peng, Che Wang, Yutong Wang, Rongrui Wang, Jixiang Liu, Tianhui Zhou, Shukun Yao
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2023/6928117
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551148114935808
author Jing Liu
Hongye Peng
Che Wang
Yutong Wang
Rongrui Wang
Jixiang Liu
Tianhui Zhou
Shukun Yao
author_facet Jing Liu
Hongye Peng
Che Wang
Yutong Wang
Rongrui Wang
Jixiang Liu
Tianhui Zhou
Shukun Yao
author_sort Jing Liu
collection DOAJ
description Purpose. As one of the most common chronic liver diseases, metabolic dysfunction-associated fatty liver disease (MAFLD) had different prognoses between mild and moderate-severe levels. Serum uric acid to serum creatinine ratio (sUA/Cr) can reflect the overall metabolic status of the body. To explore a convenient indicator to screen MAFLD and distinguish the severity of the disease, this study analyzed the correlation between sUA/Cr and the severity of MAFLD. Methods. 228 participants were enrolled and divided into 2 groups, including mild MAFLD and non-MAFLD group and moderate-severe MAFLD group, based on liver/spleen computed tomography (CT) ratios. The correlations between sUA/Cr and the severity of MAFLD were analyzed by logistic and linear regression. Receiver operating characteristics (ROCs) analyzed the predictive ability of sUA/Cr for the severity of MAFLD expressed by the area under curve (AUC). Results. The level of sUA/Cr was higher in themoderate-severe MAFLD group than mild MAFLD and non-MAFLD group (6.14 ± 1.55 vs. 5.51 ± 1.19, P=0.008). After adjustment for confounders, the correlation analysis showed that patients with elevated sUA/Cr had a higher risk of moderate-severe MAFLD (OR: 1.350, P=0.036). A higher sUA/Cr level was associated with lower liver CT values (β = −0.133, P=0.039) and liver/spleen CT ratio (β = −0.154, P=0.016). sUA/Cr had the ability to discriminate the severity of MAFLD (AUC: 0.623). Conclusion. sUA/Cr was positively associated with the risk of moderate-severe MAFLD and had the predictive ability to discriminate the moderate-severe MAFLD from mild MAFLD and non-MAFLD. The sUA/Cr level was suggested to be monitored and controlled in the screening and treatment of MAFLD.
format Article
id doaj-art-d34272cd698f4c839d97b534c0a4c070
institution Kabale University
issn 1687-8345
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-d34272cd698f4c839d97b534c0a4c0702025-02-03T06:04:50ZengWileyInternational Journal of Endocrinology1687-83452023-01-01202310.1155/2023/6928117Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine RatioJing Liu0Hongye Peng1Che Wang2Yutong Wang3Rongrui Wang4Jixiang Liu5Tianhui Zhou6Shukun Yao7Graduate School of Peking Union Medical CollegeDepartment of InfectionSchool of Qi HuangSchool of Qi HuangBeijing University of Chinese MedicineBeijing University of Chinese MedicineBeijing University of Chinese MedicineDepartment of GastroenterologyPurpose. As one of the most common chronic liver diseases, metabolic dysfunction-associated fatty liver disease (MAFLD) had different prognoses between mild and moderate-severe levels. Serum uric acid to serum creatinine ratio (sUA/Cr) can reflect the overall metabolic status of the body. To explore a convenient indicator to screen MAFLD and distinguish the severity of the disease, this study analyzed the correlation between sUA/Cr and the severity of MAFLD. Methods. 228 participants were enrolled and divided into 2 groups, including mild MAFLD and non-MAFLD group and moderate-severe MAFLD group, based on liver/spleen computed tomography (CT) ratios. The correlations between sUA/Cr and the severity of MAFLD were analyzed by logistic and linear regression. Receiver operating characteristics (ROCs) analyzed the predictive ability of sUA/Cr for the severity of MAFLD expressed by the area under curve (AUC). Results. The level of sUA/Cr was higher in themoderate-severe MAFLD group than mild MAFLD and non-MAFLD group (6.14 ± 1.55 vs. 5.51 ± 1.19, P=0.008). After adjustment for confounders, the correlation analysis showed that patients with elevated sUA/Cr had a higher risk of moderate-severe MAFLD (OR: 1.350, P=0.036). A higher sUA/Cr level was associated with lower liver CT values (β = −0.133, P=0.039) and liver/spleen CT ratio (β = −0.154, P=0.016). sUA/Cr had the ability to discriminate the severity of MAFLD (AUC: 0.623). Conclusion. sUA/Cr was positively associated with the risk of moderate-severe MAFLD and had the predictive ability to discriminate the moderate-severe MAFLD from mild MAFLD and non-MAFLD. The sUA/Cr level was suggested to be monitored and controlled in the screening and treatment of MAFLD.http://dx.doi.org/10.1155/2023/6928117
spellingShingle Jing Liu
Hongye Peng
Che Wang
Yutong Wang
Rongrui Wang
Jixiang Liu
Tianhui Zhou
Shukun Yao
Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio
International Journal of Endocrinology
title Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio
title_full Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio
title_fullStr Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio
title_full_unstemmed Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio
title_short Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio
title_sort correlation between the severity of metabolic dysfunction associated fatty liver disease and serum uric acid to serum creatinine ratio
url http://dx.doi.org/10.1155/2023/6928117
work_keys_str_mv AT jingliu correlationbetweentheseverityofmetabolicdysfunctionassociatedfattyliverdiseaseandserumuricacidtoserumcreatinineratio
AT hongyepeng correlationbetweentheseverityofmetabolicdysfunctionassociatedfattyliverdiseaseandserumuricacidtoserumcreatinineratio
AT chewang correlationbetweentheseverityofmetabolicdysfunctionassociatedfattyliverdiseaseandserumuricacidtoserumcreatinineratio
AT yutongwang correlationbetweentheseverityofmetabolicdysfunctionassociatedfattyliverdiseaseandserumuricacidtoserumcreatinineratio
AT rongruiwang correlationbetweentheseverityofmetabolicdysfunctionassociatedfattyliverdiseaseandserumuricacidtoserumcreatinineratio
AT jixiangliu correlationbetweentheseverityofmetabolicdysfunctionassociatedfattyliverdiseaseandserumuricacidtoserumcreatinineratio
AT tianhuizhou correlationbetweentheseverityofmetabolicdysfunctionassociatedfattyliverdiseaseandserumuricacidtoserumcreatinineratio
AT shukunyao correlationbetweentheseverityofmetabolicdysfunctionassociatedfattyliverdiseaseandserumuricacidtoserumcreatinineratio